Compare TWST & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWST | GAB |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2018 | N/A |
| Metric | TWST | GAB |
|---|---|---|
| Price | $29.62 | $6.20 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $46.33 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 667.8K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,572,000.00 | N/A |
| Revenue This Year | $17.89 | N/A |
| Revenue Next Year | $16.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | $4.56 |
| 52 Week High | $55.33 | $5.88 |
| Indicator | TWST | GAB |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 62.79 |
| Support Level | $25.67 | $5.90 |
| Resistance Level | $31.80 | $6.21 |
| Average True Range (ATR) | 1.96 | 0.07 |
| MACD | 0.25 | 0.02 |
| Stochastic Oscillator | 71.98 | 93.55 |
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.